loader2
Partner With Us NRI

IOL Chemicals & Pharmaceuticals Ltd share Price Today

Company details

419.55
438.80
330.85
535.90
6M Return -8.37%
1Y Return 15.16%
Mkt Cap.(Cr) 2,513.50
Volume 430,183
Div Yield 1.17%
OI
-
OI Chg %
-
Volume 430,183

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

IOL Chemicals and Pharmaceuticals announced Q4FY24 & FY24 results:

Q4FY24 Financial Highlights:

  • Total income at Rs 511 crore against Rs 596 crore 
  • EBITDA at Rs 57.6 crore against Rs 104.5 crore
  • Net profit at Rs 28.2 crore against Rs 65.3 crore 

FY24 Financial Highlights:

  • Total income at Rs 2,162.9 crore against Rs 2,242.7 crore
  • EBITDA up 3.8% YoY to Rs 261.6 crore
  • Net profit at Rs 135 crore against Rs 140 crore 

Commenting on the performance, Vikas Gupta, Joint Managing Director said, “The Company has exhibited resilient financial performance in FY24 despite challenging macro-economic environment and volatile chemical sector trajectory. We are receiving positive response in export market despite geopolitical uncertainties and supply chain obstacles. Though, the revenue growth has been sluggish, the margins were stable following Company’s sustained cost control initiatives. We believe that chemical sector turbulence would likely stabilize this financial year. In the nonIbuprofen segment, we are on track to expand our footprints in key regulated markets following approvals and certifications received last year. During the year the capex in infrastructure and automization will improve the operational efficiency and reduce the carbon footprint.”

Result PDF

View Other Company Results

IOL Chemicals & Pharmaceuticals Ltd shares SWOT Analysis

Strengths (8)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Rising Net Cash Flow and Cash from Operating activity
  • Growth in Net Profit with increasing Profit Margin (QoQ)

Weakness (8)

  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Inefficient use of assets to generate profits - ROA declining in the last 2 years

Opportunity (1)

  • RSI indicating price strength

Threats (0)

Data not found

Resistance and support

R1 438.1
R2 448.1
R3 457.4
Pivot

428.83

S1 418.9
S2 409.6
S3 399.6
EMA SMA
415.1
401.4
401.1
405.6
417.8
390.4
391.6
420.2
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2024-07-02 437.46 414429 NSE
GRAVITON RESEARCH CAPITAL LLP Bulk Sell 2024-07-02 437.55 414429 NSE
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2024-03-19 399.06 472152 NSE
Name Category Shares
MAYA DEVI POLYCOT LIMITED PROMOTER 21.54%
NCVI ENTERPRISES LIMITED PROMOTER 15.96%
NM MERCHANTILES PVT LIMITED PROMOTER 8.65%
VARINDER GUPTA PROMOTER 2.04%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

IOL Chemicals & Pharmaceuticals Ltd Stocks COMPARISON

Financials( in Cr) IOL Chemicals & Pharmaceuticals Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 428.15 1,577.30 1,512.05 4,539.30 1,175.15
% Change 1.76 -1.33 -0.08 -2.11 -0.42
Mcap Cr 2,513.50 378,447.11 122,077.93 120,504.34 118,247.59
Revenue TTM Cr 2,217.11 48,496.85 15,790.60 7,767.51 19,547.40
Net Profit TTM Cr 139.14 9,648.44 2,513.47 1,823.38 3,854.40
PE TTM 18.69 37.90 28.67 75.30 30.67
1 Year Return 15.16 50.94 48.72 24.71 102.05
ROCE 13.54 17.20 14.76 19.30 23.94
ROE 9.60 16.13 10.66 14.89 20.64
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 1,507.72 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 22,015.43 44,980.72
LAST 3M 106,765.53 41,611.09
LAST 6M 195,525.59 13,104.33
LAST 12M 310,530.02 79,314.43
IOL Chemicals and Pharmaceuticals Limited - Updates

Jul 11, 2024 l NSE Announcement

IOL Chemicals and Pharmaceuticals Limited - Loss of Share Certificates

Jul 10, 2024 l NSE Announcement

Date Action Type Ratio
Feb 16, 2024 Dividend 50
Feb 17, 2023 Dividend 40
Feb 15, 2022 Dividend 40

IOL Chemicals & Pharmaceuticals Ltd Information

Stock PE (TTM)
18.69
Promoter Holding
48.19%
Book Value
274.5067
ROCE
13.54%
ROE
9.6%
Registered Address

Trident Complex, Raikot Road Barnala, Sangrur, Punjab, 148101

Tel : 91-01679-244701-07
Email : investor:iolcp.com; contact:iolcp.com
Website : http://www.iolcp.com
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524164
NSE Code : IOLCP
Book Closure Date (Month) : Aug
BSE Group : A
ISIN : INE485C01011

FAQ’s on IOL Chemicals & Pharmaceuticals Ltd Shares

You can buy IOL Chemicals & Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy IOL Chemicals & Pharmaceuticals Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jul 12, 2024 04:04 PM the closing price of IOL Chemicals & Pharmaceuticals Ltd was Rs.428.15.

The latest PE ratio of IOL Chemicals & Pharmaceuticals Ltd as of Jul 12, 2024 04:04 PM is 18.69

The latest PB ratio of IOL Chemicals & Pharmaceuticals Ltd as of Jul 12, 2024 04:04 PM is 0.64

The 52-week high of IOL Chemicals & Pharmaceuticals Ltd share price is Rs. 535.90 while the 52-week low is Rs. 330.85

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jul 12, 2024 04:04 PM, the market cap of IOL Chemicals & Pharmaceuticals Ltd stood at Rs. 2,513.50 Cr.

Download App

Download Our App

Play Store App Store
market app